September 17, 2024

A new 30-color spectral flow cytometry panel for T cell therapy phenotypic characterization

CAR-TCR Summit 2024 -- Spectral flow cytometers have immunophenotypic analysis with panels exceeding 30 colors to provide deep insights into the immune response. Labcorp has developed a 30-color immunophenotyping panel using the Cytek Aurora Spectral Flow Cytometer. The panel backbone includes one viability dye and ten lineage markers to profile T cell, NK and B cell subsets. Nineteen additional functional markers enable the characterization of activation, exhaustion, cytotoxicity and proliferation in each subset, plus memory T cell subset delineation. Explore the data in this poster that demonstrates how spectral flow cytometry can be applied to assess T cell therapies in studies that span in vitro assessments, preclinical tumor-bearing mouse models, through clinical trials.
September 18, 2024

ATN Profile: For and beyond Alzheimer’s disease

Alzheimer’s disease (AD) is the most common form of dementia, accounting for 60%-70% of dementia cases.1 Blood-based biomarkers (BBMs) specific to AD pathology, such as beta-amyloid 42/40 and pTau217, are now available to clinicians. But this still leaves up to 40% of patients with clinical signs of mild cognitive impairment (MCI) or possible dementia without answers.
<span>The importance of the cynomolgus macaque’s origin in drug safety assessment</span>
September 17, 2024

The importance of the cynomolgus macaque’s origin in drug safety assessment

Cynomolgus macaques are the most commonly used non-human primate species for drug safety assessment. However, recent supply shortages  have brought increased attention to the genetic differences between cynomolgus macaques of varying geographic origins. It is important to examine the relevance of geographic origin for cynomolgus macaques used in regulatory toxicology studies.
<span>Key learnings from ECHA's review of the EOGRTS (OECD Test Guideline 443)</span>
September 17, 2024

Key learnings from ECHA's review of the EOGRTS (OECD Test Guideline 443)

The extended one-generation reproductive toxicity study (EOGRTS) per OECD Test Guideline 443 is a crucial test for evaluating potential reproductive and developmental effects of chemicals. Recently, the European Chemicals Agency (ECHA) conducted an extensive review of EOGRTS  studies to assess the effectiveness of this test guideline and provide recommendations for improvement. This blog post summarizes  key learnings from ECHA's review and the impacts on current and future EOGRTS study design.